Ranbaxy Laboratories Ltd

Ranbaxy Laboratories Limited (http://www.ranbaxy.com/) is a research based international pharmaceutical company serving customers in over 150 countries. 

Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharmaceutical innovator, headquartered in Tokyo, Japan. 

Ranbaxy has ground operations in 43 countries and 21 manufacturing facilities spread across 8 countries. They cover all the top 25 pharmaceutical markets of the world and have a robust presence across both developed and emerging markets.

Implementation Time: March 2014

Implementation Place: India 

Production Line No.: 1

In recent years, Indian generic drugs are popular worldwide with very low price, which arouse a purchasing boom in China as well. With a large number of foreign generic drugs expiring and related domestic policies becoming loose, China generic drug industry is welcoming an unprecedented “opportunity period”, the market size may be close to 500 billion RMB in 2015. 

However, there is supervision over import drugs according to China drug electronic supervision policies. If Indian pharmaceutical companies would like to enter China drug market, they shall implement drug electronic supervision Serialization system. Based on this, Ranbaxy Laboratories Ltd (India) chose Beijing Acctrue Technology Co., Ltd to build product Serialization system to meet China drug electronic supervision demands.

• Make Ranbaxy products meet China drug electronic supervision demands.

• Help Ranbaxy strengthen enterprise production process management.

• Realize enterprise logistics management.

• Keep well defined record of drug flow direction for Ranbaxy.

Because Indian laws only protect the process patent of pharmaceutical instead of protecting the product patent of drugs, the phenomenon of imitating new western medicine is serious in India drug market. As“a leading enterprise” of India pharmaceutical industry, Ranbaxy selected independent innovation. The cooperation with Acctrue is of great significance for Ranbaxy to standardize its enterprise production process management and enter China drug market.